{{Rsnum
|rsid=1867277
|Gene=FOXE1
|Chromosome=9
|position=97853632
|Orientation=plus
|GMAF=0.3044
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FOXE1,RP11-23B15.1
}}[[rs1867277]], also known as -283G>A, is a SNP upstream of the [[FOXE1]] gene.

Based on ~1,000 [[thyroid cancer]] patients (and an equal number of controls), a per allele odds ratio of 1.49 (CI: 1.30-1.70, p=5.9x10e-9) was found for the [[rs1867277]](A) allele. This allele is thought to be a causal variant.{{PMID|19730683|OA=1
}}

{{PMID Auto
|PMID=22282540
|Title=Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24
|OA=1
}}
{{PMID Auto
|PMID=22493691
|Title=Novel associations for hypothyroidism include known autoimmune risk loci.
|OA=1
}}

{{PMID Auto
|PMID=22736773
|Title=Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
}}

{{PMID Auto
|PMID=22882326
|Title=FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.
}}

{{PMID Auto
|PMID=23327367
|Title=Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}